CO2021004188A2 - Vacuna contra el virus de la peste porcina africana - Google Patents
Vacuna contra el virus de la peste porcina africanaInfo
- Publication number
- CO2021004188A2 CO2021004188A2 CONC2021/0004188A CO2021004188A CO2021004188A2 CO 2021004188 A2 CO2021004188 A2 CO 2021004188A2 CO 2021004188 A CO2021004188 A CO 2021004188A CO 2021004188 A2 CO2021004188 A2 CO 2021004188A2
- Authority
- CO
- Colombia
- Prior art keywords
- fever virus
- swine fever
- african swine
- virus vaccine
- viral particle
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/187—Hog cholera virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/50—Fusion polypeptide containing protease site
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/12011—Asfarviridae
- C12N2710/12022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/12011—Asfarviridae
- C12N2710/12023—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/12011—Asfarviridae
- C12N2710/12034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24041—Use of virus, viral particle or viral elements as a vector
- C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24141—Use of virus, viral particle or viral elements as a vector
- C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
La invención está dirigida a una molécula de ácido nucleico recombinante que comprende un casete génico que codifica un poliepítopo que comprende antígenos de células T de proteínas del virus de la peste porcina africana. La invención se refiere además a una partícula viral, que comprende dicha molécula de ácido nucleico recombinante, y a una partícula viral que comprende antígenos de células B del virus de la peste porcina africana. La invención se refiere además a métodos para estimular una respuesta inmune en un cerdo que comprenden administrar la molécula recombinante de la invención, y/o la partícula viral de la invención, al cerdo en una cantidad eficaz para inducir una respuesta inmune.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP18195280 | 2018-09-18 | ||
CN201910239547.XA CN110904127A (zh) | 2018-09-18 | 2019-03-27 | 非洲猪瘟病毒疫苗 |
PCT/NL2019/050614 WO2020060403A2 (en) | 2018-09-18 | 2019-09-18 | African swine fever virus vaccine |
Publications (1)
Publication Number | Publication Date |
---|---|
CO2021004188A2 true CO2021004188A2 (es) | 2021-05-20 |
Family
ID=63642765
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CONC2021/0004188A CO2021004188A2 (es) | 2018-09-18 | 2021-04-06 | Vacuna contra el virus de la peste porcina africana |
Country Status (15)
Country | Link |
---|---|
US (1) | US20220047694A1 (es) |
EP (1) | EP3852798A2 (es) |
JP (1) | JP2022500050A (es) |
KR (1) | KR20210065128A (es) |
CN (1) | CN110904127A (es) |
AU (1) | AU2019345214A1 (es) |
BR (1) | BR112021005079A2 (es) |
CA (1) | CA3112800A1 (es) |
CL (1) | CL2021000636A1 (es) |
CO (1) | CO2021004188A2 (es) |
MX (1) | MX2021003175A (es) |
PH (1) | PH12021550580A1 (es) |
TW (1) | TWI777093B (es) |
WO (1) | WO2020060403A2 (es) |
ZA (1) | ZA202101615B (es) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109810948B (zh) * | 2019-01-18 | 2021-09-17 | 中国农业科学院兰州兽医研究所 | 抗非洲猪瘟病毒k205r蛋白单克隆抗体的杂交瘤细胞株及其分泌的抗体 |
EA202192570A1 (ru) | 2019-03-27 | 2022-01-20 | Бёрингер Ингельхайм Ветмедика Гмбх | Иммуногенные композиции и вакцины, содержащие пептиды и белки вируса африканской чумы свиней, и их применение |
CN112831597A (zh) * | 2019-11-22 | 2021-05-25 | 洛阳普泰生物技术有限公司 | 用于非洲猪瘟病毒基因鉴别检验的实时荧光pcr扩增引物对、探针引物、及制备的试剂盒 |
CN111363016A (zh) * | 2020-03-30 | 2020-07-03 | 中国农业大学 | 一种非洲猪瘟免疫抗原及其制备方法和应用 |
CN111393510B (zh) * | 2020-04-02 | 2021-07-16 | 中国农业科学院兰州兽医研究所 | 一种非洲猪瘟病毒重组抗原及其应用 |
MX2022012925A (es) * | 2020-04-14 | 2023-02-16 | Plumbline Life Sciences Inc | Composición de vacuna contra la peste porcina africana. |
CN111575289A (zh) * | 2020-05-25 | 2020-08-25 | 浙江璞题生物科技有限公司 | 干扰非洲猪瘟病毒基因表达的siRNA及其应用 |
WO2022006306A2 (en) * | 2020-06-30 | 2022-01-06 | Cibus Biotechnologies, Inc. | Compositions for genome editing and methods of use thereof |
CN113897395B (zh) * | 2020-07-06 | 2023-10-03 | 嘉兴安宇生物科技有限公司 | 一种非洲猪瘟的重组腺病毒疫苗及其构建方法 |
CN113897391B (zh) * | 2020-07-06 | 2023-08-22 | 嘉兴安宇生物科技有限公司 | 一种非洲猪瘟的重组腺病毒疫苗及其构建方法 |
CN113201507B (zh) * | 2020-07-10 | 2022-02-22 | 浙江海隆生物科技有限公司 | 一种重组的伪狂犬病病毒及其疫苗组合物 |
CN113896772B (zh) * | 2020-08-26 | 2023-08-18 | 中国农业科学院兰州兽医研究所 | 一类促进猪机体产生非洲猪瘟病毒抗原特异性免疫应答的多肽及其应用 |
CN112472801A (zh) * | 2020-12-22 | 2021-03-12 | 华南农业大学 | 非洲猪瘟p30、p54、p72和B602L的DNA疫苗和亚单位疫苗及其制备方法与应用 |
CN113308422A (zh) * | 2021-07-30 | 2021-08-27 | 山东格研生物技术有限公司 | 一种博兹曼军团菌分离培养基及其制备方法 |
WO2023027402A1 (ko) * | 2021-08-27 | 2023-03-02 | 주식회사 바이오앱 | 아프리카 돼지열병 바이러스 유래 항원 단백질을 포함하는 아프리카 돼지열병의 예방용 백신 |
CN114437236B (zh) * | 2022-01-11 | 2023-06-27 | 中国农业科学院兰州兽医研究所 | 一种重组非洲猪瘟病毒多表位融合蛋白、制备及其应用 |
CN114940705A (zh) * | 2022-05-05 | 2022-08-26 | 中国农业科学院兰州兽医研究所 | 非洲猪瘟病毒p30抗原表位蛋白及其制备方法和用途 |
CN114989266B (zh) * | 2022-06-16 | 2024-02-13 | 华中农业大学 | 一种非洲猪瘟病毒pA104R蛋白免疫抑制相关氨基酸位点及其应用 |
CN115109800B (zh) * | 2022-06-22 | 2024-05-03 | 吉林大学 | 表面展示猪传染性胃肠炎病毒s1蛋白的细菌样颗粒的制备方法 |
CN115806600B (zh) * | 2022-09-30 | 2024-04-05 | 扬州大学 | 一种鸡滑液囊支原体蛋白GrpE及其制备方法、作为亚单位疫苗的应用 |
CN115925887B (zh) * | 2022-10-27 | 2024-02-09 | 华中农业大学 | 非洲猪瘟病毒pA104R蛋白免疫优势性B细胞抗原表位及其单克隆抗体与应用 |
CN116407624B (zh) * | 2023-04-14 | 2024-04-09 | 吉林省农业科学院(中国农业科技东北创新中心) | 一种鸡传染性支气管炎细菌样颗粒疫苗的制备方法和应用 |
CN116656731B (zh) * | 2023-05-25 | 2024-04-12 | 军事科学院军事医学研究院军事兽医研究所 | 一种表达非洲猪瘟病毒多种蛋白的重组金丝雀痘病毒及其构建方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5888809A (en) | 1997-05-01 | 1999-03-30 | Icos Corporation | Hamster EF-1α transcriptional regulatory DNA |
AUPO856097A0 (en) * | 1997-08-14 | 1997-09-04 | Commonwealth Scientific And Industrial Research Organisation | Vector |
SE0003538D0 (sv) | 2000-09-29 | 2000-09-29 | Isconova Ab | New immunogenic complex |
WO2009008888A1 (en) * | 2007-07-10 | 2009-01-15 | Matthias Rath | African swine virus polypeptides as vaccines and its therapeutic use thereof |
EP2168987A1 (en) | 2008-09-22 | 2010-03-31 | Mucosis B.V. | Multifunctional linker protein containing an antibody against hemagglutinin, a conserved influenza antigen and an immunostimulating carrier binding domain |
EA025280B1 (ru) | 2010-03-09 | 2016-12-30 | Амир Максютов | Полиэпитопные конструкции и способы их получения и применения |
CN101825633B (zh) * | 2010-04-23 | 2013-01-30 | 天津出入境检验检疫局动植物与食品检测中心 | 用于检测非洲猪瘟病毒的竞争elisa试剂盒 |
CN101991848B (zh) * | 2010-11-10 | 2013-03-27 | 中国农业科学院上海兽医研究所 | 猪瘟合成肽疫苗及其应用 |
EP3778904A1 (en) | 2012-10-28 | 2021-02-17 | Bavarian Nordic A/S | Pr13.5 promoter for robust t-cell and antibody responses |
WO2017096341A2 (en) * | 2015-12-04 | 2017-06-08 | The Texas A&M University System | Adenovirus-vectored multivalent vaccine |
-
2019
- 2019-03-27 CN CN201910239547.XA patent/CN110904127A/zh active Pending
- 2019-09-18 JP JP2021514359A patent/JP2022500050A/ja active Pending
- 2019-09-18 TW TW108133648A patent/TWI777093B/zh active
- 2019-09-18 AU AU2019345214A patent/AU2019345214A1/en active Pending
- 2019-09-18 WO PCT/NL2019/050614 patent/WO2020060403A2/en unknown
- 2019-09-18 US US17/276,790 patent/US20220047694A1/en active Pending
- 2019-09-18 KR KR1020217011248A patent/KR20210065128A/ko unknown
- 2019-09-18 CA CA3112800A patent/CA3112800A1/en active Pending
- 2019-09-18 MX MX2021003175A patent/MX2021003175A/es unknown
- 2019-09-18 EP EP19828843.3A patent/EP3852798A2/en active Pending
- 2019-09-18 BR BR112021005079-5A patent/BR112021005079A2/pt unknown
-
2021
- 2021-03-10 ZA ZA2021/01615A patent/ZA202101615B/en unknown
- 2021-03-16 CL CL2021000636A patent/CL2021000636A1/es unknown
- 2021-03-16 PH PH12021550580A patent/PH12021550580A1/en unknown
- 2021-04-06 CO CONC2021/0004188A patent/CO2021004188A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
EP3852798A2 (en) | 2021-07-28 |
PH12021550580A1 (en) | 2021-11-29 |
ZA202101615B (en) | 2023-04-26 |
TWI777093B (zh) | 2022-09-11 |
MX2021003175A (es) | 2021-05-14 |
JP2022500050A (ja) | 2022-01-04 |
CN110904127A (zh) | 2020-03-24 |
CA3112800A1 (en) | 2020-03-26 |
KR20210065128A (ko) | 2021-06-03 |
WO2020060403A3 (en) | 2020-05-14 |
BR112021005079A2 (pt) | 2021-06-08 |
TW202033538A (zh) | 2020-09-16 |
US20220047694A1 (en) | 2022-02-17 |
WO2020060403A2 (en) | 2020-03-26 |
CL2021000636A1 (es) | 2021-10-01 |
AU2019345214A1 (en) | 2021-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO2021004188A2 (es) | Vacuna contra el virus de la peste porcina africana | |
BR112013020070A8 (pt) | moléculas de ácido nucleico que codificam novos antígenos de herpes, vacina compreendendo as mesmas e métodos de uso das mesmas | |
MX2023012264A (es) | Mejora del efecto de celulas t dise?adas por car por medio de vacunacion con acido nucleico. | |
CO2017007105A2 (es) | Nuevos virus de tilapia | |
BR112018017307A2 (pt) | molécula de ácido nucleico isolada, composição, e, métodos para indução de uma resposta imune contra um zika vírus, para tratamento de um indivíduo e para prevenção de uma infecção por zika vírus | |
MX2021015465A (es) | Vacuna para fiebre porcina africana. | |
EA202091513A1 (ru) | Вакцины против вируса гепатита b (hbv) и их применение | |
EA201891415A8 (ru) | Антигены вируса иммунодефицита человека, векторы, композиции и способы их применения | |
AR110632A1 (es) | Vectores del adenovirus canino | |
RU2015135890A (ru) | Композиция вакцины | |
EA201590597A1 (ru) | Коровый белок вируса гепатита в и поверхностный антигенный белок и содержащая их вакцина | |
EA201891124A3 (ru) | Новые мукозные адъюванты и системы доставки | |
BR112016023688A2 (pt) | célula hospedeira, métodos para produzir um bioconjugado, para tratar ou prevenir uma infecção por pseudomonas em um indivíduo e para induzir uma resposta imune contra pseudomonas em um indivíduo, bioconjugado, composição, uso de um bioconjugado ou uma composição, e, sequência de ácido nucleico isolada | |
AR080585A1 (es) | Vacunacion contra tumores que comprende una respuesta inmune humoral contra proteinas propias | |
MX2022007398A (es) | Vacunas contra el virus de la fiebre porcina africana y métodos para usarlas. | |
PH12015501721A1 (en) | Porcine parvovirus 5b, methods of use and vaccine | |
PH12017501100B1 (en) | Recombinant swinepox virus and vaccines | |
AR109540A1 (es) | Moléculas promotoras para expresar antígenos virales | |
CY1125328T1 (el) | Ανασυνδυασμενο εμβολιο ιου λευχαιμιας αιλουροειδων περιεχοντας βελτιστοποιημενο γονιδιο φακελου ιου λευχαιμιας αιλουροειδων | |
CO2023014970A2 (es) | Vacuna contra el coronavirus que comprende una proteina mosaico | |
WO2019139648A3 (en) | Dna antibody constructs for use against ebola virus | |
AR125310A1 (es) | Vacuna contra el coronavirus que comprende una proteína mosaico | |
Lazarte | Enhancement of immunogenicity in glycoprotein-based DNA vaccine by the addition of DDx41, a molecular adjuvant | |
RU2016147543A (ru) | Способ применения ДНК-вакцинного вектора, созданного на основе кодон-оптимизированного гена гликопротеина (белкаG) вируса бешенства, для профилактики бешенства | |
AR104231A1 (es) | Proteínas de fusión inmunogénicas para el tratamiento del cáncer |